Neuroscientists have developed a new treatment approach for a language disorder that combines traditional speech therapy with noninvasive electrical stimulation of the brain. Brain stimulation helped ...

Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...